Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the intervening years between initial treatment and relapse, occult cancers are maintained in an apparent state of dormancy that is poorly understood. In this study, we applied a probabilistic mathematical model to long-term follow-up studies of postresection patients to investigate the factors involved in mediating breast cancer dormancy. Our results suggest that long-term dormancy is maintained most often by just one growth-restricted dangerous micrometastasis. Analysis of the empirical data by Approximate Bayesian Computation indicated that patients in dormancy have between 1 and 5 micrometastases at 10 years postresection, when they escape growth ...
<div><p>Breast cancers can recur after removal of the primary tumor and treatment to eliminate remai...
The purpose of this study was to characterize the recurrence dynamics in breast cancer patients afte...
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients deve...
Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the inter...
Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the inter...
Breast cancer patients have an anomalously high rate of relapse many years--up to 25 years--after ap...
<div><p>Breast cancer patients have an anomalously high rate of relapse many years–up to 25 years–af...
Abstract Many tumours undergo periods in which they apparently do not grow but remain at a roughly c...
Abstract. Many tumours undergo periods in which they apparently do not grow but remain at a roughly ...
We review our work over the past 14 years that began when we were first confronted with bimodal rela...
Frailty models are here proposed in the tumor dormancy framework, in order to account for possible u...
A small international group has recently challenged fundamental concepts in breast cancer. As a guid...
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients deve...
Breast cancer recurrence may occur at variable times following primary tumor removal. The correspond...
Delayed recurrences, common in breast cancer, are well explained by the concept of tumour dormancy. ...
<div><p>Breast cancers can recur after removal of the primary tumor and treatment to eliminate remai...
The purpose of this study was to characterize the recurrence dynamics in breast cancer patients afte...
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients deve...
Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the inter...
Late relapse of breast cancer can occur more than 25 years after primary diagnosis. During the inter...
Breast cancer patients have an anomalously high rate of relapse many years--up to 25 years--after ap...
<div><p>Breast cancer patients have an anomalously high rate of relapse many years–up to 25 years–af...
Abstract Many tumours undergo periods in which they apparently do not grow but remain at a roughly c...
Abstract. Many tumours undergo periods in which they apparently do not grow but remain at a roughly ...
We review our work over the past 14 years that began when we were first confronted with bimodal rela...
Frailty models are here proposed in the tumor dormancy framework, in order to account for possible u...
A small international group has recently challenged fundamental concepts in breast cancer. As a guid...
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients deve...
Breast cancer recurrence may occur at variable times following primary tumor removal. The correspond...
Delayed recurrences, common in breast cancer, are well explained by the concept of tumour dormancy. ...
<div><p>Breast cancers can recur after removal of the primary tumor and treatment to eliminate remai...
The purpose of this study was to characterize the recurrence dynamics in breast cancer patients afte...
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients deve...